Probe set for detection of Filovirus, and method for detection of Filovirus using the same

A set of target capture probes with 60 bp overlap and biotin labeling enhances filovirus detection sensitivity and accuracy in clinical samples, overcoming limitations of existing methods by improving read data and depth in NGS analysis.

KR103045057B1Active Publication Date: 2026-11-10AGENCY FOR DEFENSE DEV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
KR1020250037252
Authority / Receiving Office
KR · KR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2025-03-24
Publication Date
2026-11-10
Estimated Expiration
2045-03-24

AI Technical Summary

Technical Problem

Existing methods for detecting filoviruses, such as Ebola and Marburg viruses, face challenges in accurately and efficiently identifying low concentrations or trace amounts of these pathogens in clinical samples without the need for virus isolation culture.

Method used

A set of target capture probes, each 120 bp long with a 60 bp overlap, labeled with biotin at the 5' end, is used to specifically target and amplify filovirus genes in samples, followed by next-generation sequencing (NGS) to enhance sensitivity and accuracy.

Benefits of technology

The method enables high-sensitivity detection and accurate sequencing of filoviruses, significantly improving read data, base coverage, and depth compared to conventional methods like SISPA, allowing for rapid and precise identification of multiple filovirus types in clinical samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 112025033090949-PAT00003_ABST
    Figure 112025033090949-PAT00003_ABST
Patent Text Reader

Abstract

The present invention provides a probe set for rapidly and accurately detecting trace amounts of filovirus in a sample, and a method for detecting filovirus using the same to perform targeted capture and next-generation sequencing analysis.
Need to check novelty before this filing date? Find Prior Art